Never miss a story

Get subscribed to our newsletter


×
Work risks and severity are the factors which affect the people during the dispensing of COVID vaccine. Pixabay

The government would look at two key considerations for prioritization of the COVID-19 vaccine — the occupational hazard and risk of exposure to infection, and secondly, the risk of developing severe disease and increased mortality, Union Health Minister Harsh Vardhan said on Sunday.

Besides, the supply of vaccines is anticipated to be available in limited quantities in the beginning, he added, during ‘Sunday Samvaad’, a weekly webinar which he hosts every Sunday for his social media audience.


“In a huge country like India, it is critical to prioritize vaccine delivery based on various factors such as per risk of exposure, co-morbidity among various population groups, the mortality rate among COVID cases, and several others,” he said while adding that India is looking at the availability of several different types of vaccines.

Follow NewsGram on Facebook to stay updated.

On the issue of emergency authorization of COVID vaccines in India, the Minister said that the issue is being deliberated at present.

“Adequate safety and efficacy data are required for emergency use authorization of vaccine for ensuring patient safety. Further course of action will depend on the data generated,” he added.


The third vaccine candidate under human trial is ZyCoV-D, developed by Zydus Cadila. This candidate is now under Phase-1 and Phase-2 of clinical trials. Unsplash

Harsh Vardhan also informed that COVID-19 vaccines currently in trial in India are two and three-dose vaccines.

“Vaccine by the Serum Institute of India and Bharat Biotech require two doses while the Cadila Healthcare vaccine requires three doses. For other vaccines in preclinical stages, the dosing is being tested,” he stated.

Three potential vaccines are being tested in India, including Covishield which was developed jointly by the Jenner Institute of University of Oxford and pharma giant AstraZeneca.

Covishield is in Phase-2 and Phase-3 human trials and, if successful, will be mass-produced by the Pune-based Serum Institute of India (SII), one of the world’s largest manufacturers of vaccines. Its trials in India are running at 17 locations across the country.

Besides, Bharat Biotech, in collaboration with the Indian Council of Medical Research and the National Institute of Virology, is conducting Phase-1 and Phase-2 clinical trials of its vaccine candidate COVAXIN.


The government would look at two key considerations for prioritization of the Covid-19 vaccine — the occupational hazard and risk of exposure to infection, and secondly, the risk of developing severe disease and increased mortality. Unsplash

The third vaccine candidate under human trial is ZyCoV-D, developed by Zydus Cadila. This candidate is now under Phase-1 and Phase-2 of clinical trials.

The World Health Organisation (WHO) had released the ‘Draft landscape of Covid-19 candidate vaccines’, on September 30, where it said that as many as 191 vaccine candidates are in various stages of development across the globe. Among these, 41 candidate vaccines have made their way into clinical trials while ten have entered the third phase of clinical trials.

Also Read: Households Expect Inflation to Remain Elevated Over Next One Year: Survey

Harsh Vardhan also said that the government is open to assess the feasibility of introducing several Covid-19 vaccines in the country as per their availability for the Indian population.

“Considering the large population size of India, one vaccine or vaccine manufacturer will not be able to fulfill the requirements of vaccinating the whole country. Therefore, we are open to assessing the feasibility of introducing several Covid-19 vaccines in the country as per their availability for the Indian population.” (IANS)


Popular

Photo by GOI.

New Education Policy 2020

On the first day of the two-day meeting of BJP and Rashtriya Swayamsevak Sangh (RSS) leaders on Tuesday, discussions were held on important issues related to education and the National Education Policy-2020.

Apart from senior RSS leader Suresh Soni, representatives of various organisations associated with the Sangh Parivar -- working in the field of education -- were present in the meeting in New Delhi.

According to sources, Union Education Minister Dharmendra Pradhan, who attended the meeting on behalf of the government, shared information related to the National Education Policy-2020 and the government's policy on important issues related to the education sector. Pradhan also shared details of the efforts being made by the government in the field of education.

Discussions were also held regarding the impact of the situation arising out of Corona and how much it has affected the education sector.

In the meeting, the RSS leaders asked several questions and provided suggestions to the Union Minister regarding the education policy of the government.

According to the sources, RSS wants the policy to be implemented expeditiously. All aspects related to the policy were discussed in Tuesday's meeting.

On the second and the last day of the meeting on Wednesday, special issues related to education will be discussed in which representatives of various organisations of the Sangh, Union Ministers and several BJP leaders will be take part.

Meanwhile, in order to convey its point of view to the government on various issues, the Sangh keeps on calling such coordination meetings related to specific issues, in which RSS representatives -- working in that particular area -- provide feedback to the government. (IANS/JB)

Keywords: BJP, RSS, New Education Policy, Education, India


Travelers sometimes encounter the risk of being scammed at the departures or during the flights. This risk becomes more obvious when you don't speak the familiar language or don't have complete knowledge about the complex procedures.

By- Steven

An old saying, "prevention is better than cure" should be the first scoop in the cup of excitement if you are out to explore the world. To make traveling safe, make sure you check some practical safety tips before and while on the journey.

Keep Reading Show less
Flickr

Facebook is used regularly by more than 2 billion people; it is probably an essential component of several people's online presence and daily routine.

As a company, Facebook doesn't need much of an introduction. If you're not a member of the network, chances are you've seen or at the very least heard of it. Facebook is generally recognized as the most utilized social networking site. Facebook is used regularly by more than 2 billion people; it is probably an essential component of several people's online presence and daily routine.

The software for a website called "Facemash" was written by Zuckerberg, then a second-year Harvard student, in the year 2003. He put his talent to improper use by hacking into the security network of Harvard. To fill his new website, he duplicated the student ID pictures used by the dorms and uploaded them there. Anyone who visited the site could see photos of two students side-by-side and choose who among the two was "hot" or "not." Facemash opened on October 28, 2003, but a few days later, it was closed. Zuckerberg faced significant allegations of breach of security, infringement of intellectual property rights, invasion of personal privacy, and even expulsion from Harvard.

Keep reading... Show less